More on VRDN
Data
Upcoming Events
News
|
|||||
|---|---|---|---|---|---|
| Prev. Close | $23.88 |
|
|||
| Open | $24.17 | ||||
| 52 Wk High | $ | ||||
| 52 Wk Low | $ | ||||
| Day High | $24.50 | ||||
| Day Low | $23.80 | ||||
| P/E | N/A | ||||
| EPS | $ | ||||
| Volume | 433,102 | ||||
- Form 4 Viridian Therapeutics, For: Sep 27 Filed by: Beetham Thomas W.
- Form 4 Viridian Therapeutics, For: Sep 27 Filed by: Mahoney Stephen F.
- Form SC 13D/A Viridian Therapeutics, Filed by: Fairmount Funds Management LLC
- Form 4 Viridian Therapeutics, For: Sep 13 Filed by: Fairmount Healthcare Fund II L.P.
- Viridian Therapeutic (VRDN) PT Raised to $44 at RBC Capital
- Form 424B5 Viridian Therapeutics,
- Form 8-K Viridian Therapeutics, For: Sep 11
- Viridian Therapeutics (VRDN) Prices Upsized 10.67M Share Offering at $18.75/sh
- Viridian Therapeutic (VRDN) PT Raised to $31 at Goldman Sachs
- Viridian Therapeutics Announces Pricing of Upsized Public Offering of Shares of Common Stock and Preferred Stock
Entities mentioned with VRDN
- 13G | View Related Stories »
- FDA | View Related Stories »
- Jefferies & Co | View Related Stories »
- Earnings | View Related Stories »
- Twitter | View Related Stories »
- F1 | View Related Stories »
- Maynard Um | View Related Stories »
- Mark Zuckerberg | View Related Stories »
- Show More...
